Clinical Trials Directory

Trials / Completed

CompletedNCT04473742

Effects of Silica and Asbestos Fibres on the Efferocytosis Capacities of Macrophages

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
23 (actual)
Sponsor
Rennes University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Evaluation of the efferocytosis capacities of blood Monocyte Derived Macrophages (MDM) from patients with a history of asbestosis or silica exposure and comparison of these capacities with those of MDM from healthy donors.

Detailed description

Patients with a proven history or current exposure will have 4 EDTA tubes drawn, approximately 24mL of fresh whole blood for efferocytosis assessment and : * 2 x 6mL serum tubes for the assessment of Antinuclear Antibody (ANA) positivity, serum high-mobility group box 1 (HMGB1) and osteopontin for patients exposed to asbestos * 1 x 6mL serum tube for serum HMGB1 and osteopontin for patients exposed to silica

Conditions

Interventions

TypeNameDescription
BIOLOGICALBlood collection4 EDTA tubes for 24 mL blood collection
BIOLOGICALBlood sample2 drying tubes for 12 mL blood collection
BIOLOGICALBlood sample1 drying tube for 6 mL blood collection

Timeline

Start date
2021-03-31
Primary completion
2021-12-15
Completion
2021-12-15
First posted
2020-07-16
Last updated
2022-01-04

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04473742. Inclusion in this directory is not an endorsement.